COVID-19大流行期间儿童青少年糖尿病发病率:系统综述与Meta分析
本系统综述与Meta分析检索Medline、Embase、Cochrane、Scopus、Web of Science及灰色文献(2020年1月1日至2023年3月28日),纳入报告19岁以下人群大流行期间与大流行前糖尿病发病差异、且两期观察各至少12个月的研究。42项研究含102 984例新发糖尿病;17项研究38 149例的1型糖尿病Meta分析显示,大流行第1年发病率高于大流行前(IRR 1.14;95%CI 1.08-1.21),大流行第13-24个月也升高(IRR 1.27;95%CI 1.18-1.37)。15项研究报告DKA发生率,大流行期间高于大流行前(IRR 1.26;95%CI 1.17-1.36)。
要点
- 大流行第1年儿童青少年1型糖尿病发病率高于大流行前:IRR 1.14(95%CI 1.08-1.21),17项研究38 149例。
- 大流行第13-24个月1型糖尿病发病率仍高于大流行前:IRR 1.27(95%CI 1.18-1.37)。
- 以新发糖尿病起病的DKA发生率在大流行期间高于大流行前:IRR 1.26(95%CI 1.17-1.36),15项研究。
- 10项研究(23.8%)报告两期均有2型糖尿病新发病例,但未报告发病率,结果未合并。
- 作者认为,糖尿病儿童青少年数量增长可能需要增加资源与支持。
适用人群与场景
- 19岁以下儿童青少年,报告大流行期间与大流行前新发糖尿病病例差异的研究人群。
- 纳入研究要求大流行期间及大流行前各至少12个月的观察期,且以英文发表。
研究设计与关键结果
- 系统综述与Meta分析,检索Medline、Embase、Cochrane、Scopus、Web of Science及灰色文献,时间2020年1月1日至2023年3月28日,遵循MOOSE报告规范。
- 共纳入42项研究、102 984例新发糖尿病病例;1型糖尿病发病率Meta分析纳入17项研究、38 149例。
- 大流行第1年1型糖尿病发病率高于大流行前:IRR 1.14(95%CI 1.08-1.21)。
- 大流行第13-24个月1型糖尿病发病率高于大流行前:IRR 1.27(95%CI 1.18-1.37)。
- 15项研究(35.7%)报告DKA发生率,大流行期间高于大流行前:IRR 1.26(95%CI 1.17-1.36)。
- 10项研究(23.8%)报告两期均有2型糖尿病新发病例,但未报告发病率,结果未合并,仅作描述性总结。
证据类型、等级与局限
- 证据类型:系统综述与Meta分析(观察性研究),遵循MOOSE报告规范。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,糖尿病儿童青少年数量增长可能需要增加资源与支持。
- 作者指出,未来研究需要评估该趋势是否持续,并可能有助于阐明解释时间变化的潜在机制。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: There are reports of increasing incidence of pediatric diabetes since the onset of the COVID-19 pandemic. Given the limitations of individual studies that examine this association, it is important to synthesize estimates of changes in incidence rates.
OBJECTIVE: To compare the incidence rates of pediatric diabetes during and before the COVID-19 pandemic.
DATA SOURCES: In this systematic review and meta-analysis, electronic databases, including Medline, Embase, the Cochrane database, Scopus, and Web of Science, and the gray literature were searched between January 1, 2020, and March 28, 2023, using subject headings and text word terms related to COVID-19, diabetes, and diabetic ketoacidosis (DKA).
STUDY SELECTION: Studies were independently assessed by 2 reviewers and included if they reported differences in incident diabetes cases during vs before the pandemic in youths younger than 19 years, had a minimum observation period of 12 months during and 12 months before the pandemic, and were published in English.
DATA EXTRACTION AND SYNTHESIS: From records that underwent full-text review, 2 reviewers independently abstracted data and assessed the risk of bias. The Meta-analysis of Observational Studies in Epidemiology (MOOSE) reporting guideline was followed. Eligible studies were included in the meta-analysis and analyzed with a common and random-effects analysis. Studies not included in the meta-analysis were summarized descriptively.
MAIN OUTCOMES AND MEASURES: The primary outcome was change in the incidence rate of pediatric diabetes during vs before the COVID-19 pandemic. The secondary outcome was change in the incidence rate of DKA among youths with new-onset diabetes during the pandemic.
RESULTS: Forty-two studies including 102 984 incident diabetes cases were included in the systematic review. The meta-analysis of type 1 diabetes incidence rates included 17 studies of 38 149 youths and showed a higher incidence rate during the first year of the pandemic compared with the prepandemic period (incidence rate ratio [IRR], 1.14; 95% CI, 1.08-1.21). There was an increased incidence of diabetes during months 13 to 24 of the pandemic compared with the prepandemic period (IRR, 1.27; 95% CI, 1.18-1.37). Ten studies (23.8%) reported incident type 2 diabetes cases in both periods. These studies did not report incidence rates, so results were not pooled. Fifteen studies (35.7%) reported DKA incidence and found a higher rate during the pandemic compared with before the pandemic (IRR, 1.26; 95% CI, 1.17-1.36).
CONCLUSIONS AND RELEVANCE: This study found that incidence rates of type 1 diabetes and DKA at diabetes onset in children and adolescents were higher after the start of the COVID-19 pandemic than before the pandemic. Increased resources and support may be needed for the growing number of children and adolescents with diabetes. Future studies are needed to assess whether this trend persists and may help elucidate possible underlying mechanisms to explain temporal changes.
参考来源
- D'Souza D, Empringham J, Pechlivanoglou P, et al. Incidence of Diabetes in Children and Adolescents During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2023. PMID: 37389869. doi:10.1001/jamanetworkopen.2023.21281
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。